Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Onl

A Class II recall has been issued for Accord Healthcare's Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), in 1000-count bottles, NDC 16729-455-17, manufactured by Intas Pharmaceuticals in India. The recall notice cites the product as a subpotent drug. The affected product is labeled Rx Only and was manufactured for Accord Healthcare, Inc. of Raleigh, NC.

Most relevant for: Patients taking levothyroxine sodium 150 mcg tablets from Accord Healthcare for thyroid hormone replacement therapy

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.